Skip to main content

TaiRx looks to commercialize therapy targeting drug-resistant cancers – Washington Business Journal

By November 5, 2018News
bhi-tairx-logo

bhi-tairx-logo

TaiRx, a joint venture between Rockville-based BioHealth Innovation Inc. and Taiwan pharmaceutical company TaiRx Inc., is looking to raise around $5 million.

{iframe}https://www.bizjournals.com/washington/news/2018/10/31/how-maryland-s-newest-company-plans-to-take-down.html{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.